|Articles|August 12, 2022
Supplements and Featured Publications
- VIVJOA™ (OTESECONAZOLE) CLINICAL MONOGRAPH
VIVJOA™ (OTESECONAZOLE) CLINICAL MONOGRAPH
Advertisement
This Clinical Monograph provides Pharmacy and Therapeutics (P&T) Committee members with current, detailed information about a specific therapeutic agent to help them manage their formularies and establish medication-related policies. The monograph supplies information about pharmacology, clinical studies, FDA-approved indications, safety, efficacy, acquisition costs, and other pharmacoeconomic variables, along with additional P&T committee considerations, in a convenient package.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5
